308nm Ultraviolet Light Therapy Device (XWYL-401A, XWYL-403A)

K262885 · Guangxi Hope Medical Devices Technology Co., Ltd. · FTC · Oct 14, 2026 · General, Plastic Surgery

Device Facts

Record IDK262885
Device Name308nm Ultraviolet Light Therapy Device (XWYL-401A, XWYL-403A)
ApplicantGuangxi Hope Medical Devices Technology Co., Ltd.
Product CodeFTC · General, Plastic Surgery
Decision DateOct 14, 2026
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.4630
Device ClassClass 2
AttributesTherapeutic

Indications for Use

The 308nm Ultraviolet Light Therapy Device is an Ultraviolet Light Emitting Medical Device. It is intended for use in localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and leukoderma on all skin types (I-VI).

Device Story

Portable handheld device for localized phototherapy; utilizes LED light board to emit narrowband 308nm UVB radiation. Operated by physician or patient (home/clinic/hospital) for treatment of diagnosed skin disorders. Device consists of host, LED board, heat dissipation module, control/drive circuits, and rechargeable Li-ion battery. User applies device to intact skin; output is controlled UVB light. Benefits include targeted treatment of dermatologic conditions. Safety features include compliance with IEC 60601-2-83 for home light therapy and IEC 62471 for photobiological safety.

Clinical Evidence

Bench testing only. No clinical data provided. Evidence includes biocompatibility testing (ISO 10993-5, -10, -23), electrical safety (IEC 60601-1, -1-2, -1-11, -2-83), battery safety (IEC 62133-2), photobiological safety (IEC 62471), and software verification/validation.

Technological Characteristics

Handheld LED-based phototherapy device; 308nm narrowband UVB output; 13mW/cm2 irradiance; 4.5cm2 treatment area. Powered by 3.7V 2600mAh Li-ion battery (IEC 62133-2 compliant). Dimensions: XWYL-401A (170x39x37mm), XWYL-403A (200x39x37mm). Standards: IEC 60601-1, IEC 60601-1-2, IEC 60601-1-11, IEC 60601-2-83, IEC 62471.

Indications for Use

Indicated for localized phototherapeutic treatment of dermatologic conditions including psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma in patients of all skin types (I-VI). Intended for use on intact skin only; excludes eyes.

Regulatory Classification

Identification

An ultraviolet lamp for dermatologic disorders is a device (including a fixture) intended to provide ultraviolet radiation of the body to photoactivate a drug in the treatment of a dermatologic disorder if the labeling of the drug intended for use with the device bears adequate directions for the device's use with that drug.

Predicate Devices

Submission Summary (Full Text)

{1} **U.S. FOOD & DRUG** ADMINISTRATION October 14, 2026 Guangxi Hope Medical Devices Technology Co., Ltd. % Qin Wang RA Specialist Flying Drug & Medical Compliance Service Co., Ltd. Rm. 1505 Zhenye International Business Center, Qianhai Rd. Shenzhen, Guangdong 518055 China Re: K262885 Trade/Device Name: 308nm Ultraviolet Light Therapy Device (XWYL-401A, XWYL-403A) Regulation Number: 21 CFR 878.4630 Regulation Name: Ultraviolet Lamp For Dermatologic Disorders Regulatory Class: Class II Product Code: FTC Dated: August 17, 2026 Received: August 17, 2026 Dear Qin Wang: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Before making any change significantly affecting the safety or effectiveness of the device, you must submit a new premarket notification in accordance with 21 CFR 807.81. Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {2} K262885 - Qin Wang Page 2 When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory- {3} K262885 - Qin Wang Page 3 assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, YAN FU-S Digitally signed by YAN FU-S Date: 2026.10.14 15:44:14 -04'00' for Tanisha Hithe Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {4} DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration # **Indications for Use** Form Approved: OMB No. 0910-0120 Expiration Date: 07/31/2026 See PRA Statement below. 510(k) Number (if known) K262885 Device Name 308nm Ultraviolet Light Therapy Device (XWYL-401A, XWYL-403A) Indications for Use (Describe) The 308nm Ultraviolet Light Therapy Device is an Ultraviolet Light Emitting Medical Device. It is intended for use in localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and leukoderma on all skin types (I-VI). Type of Use (Select one or both, as applicable) ☑ Prescription Use (Part 21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) **CONTINUE ON A SEPARATE PAGE IF NEEDED.** This section applies only to requirements of the Paperwork Reduction Act of 1995. **\*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.\*** The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov *"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."* FORM FDA 3881 (8/23) Page 1 of 1 PSC Publishing Services (301) 443-6740 EF {5} Guangxi Hope Medical Devices Technology Co., Ltd. 510(K) Summary of 308nm Ultraviolet Light Therapy Device # 510(k) Summary K262885 "510(k) Summary" as required by 21 CFR Part 807.92. # I. Submitter Guangxi Hope Medical Devices Technology Co., Ltd. Address: 1st and 2nd floor, Building 3,Yulin Traditional Chinese Medicine Health Industrial Park, Yulin City, Guangxi, China Contact person: Bing Wang Title: General Manager Tel: +86 0771-2298833 E-mail: 760476020@qq.com Date: August 17, 2026 # II. Subject Device Trade Name: 308nm Ultraviolet Light Therapy Device Model(s): XWYL-401A, XWYL-403A Common Name: Light, ultraviolet, dermatological Regulation Name: Ultraviolet lamp for dermatologic disorders. Regulation Number: 878.4630 Product Code: FTC Review Panel: General & Plastic Surgery # III. Predicate Device/ Reference Device | No. | 510(K) number | Product code | Classification | Trade name | | --- | --- | --- | --- | --- | | 1 | K170489 | FTC | Class II | Skylit Phototherapy System | | 2 | K191571 | FTC | Class II | UV Radiation Treatment System Model: YK-6000A | # IV. Device Description The 308nm Ultraviolet Light Therapy Device is a portable medical device, which consists of LED light board, heat dissipation module, control circuit, drive circuit, battery. It is a therapeutic product under the direction of a physician for individuals who require ultraviolet radiation for diagnosed skin disorders, which can be used in hospital, clinics and households. The device is mainly composed of a host and charging cable. The LED light board of the device host contains light emitting diodes (LEDs), which create narrowband UVB light centered at a wavelength 308nm for the purpose of phototherapy. They are intended to be use in localized phototherapeutic treatment of dermatologic conditions(excluding eyes), such as psoriasis, vitiligo, seborrheic dermatitis, atopic dermatitis, and leukoderma. It is for the partial treatment and is intended to be used on intact skin only. # V. Intended Use Page 1 of 7 {6} Guangxi Hope Medical Devices Technology Co., Ltd. 510(K) Summary of 308nm Ultraviolet Light Therapy Device The 308nm Ultraviolet Light Therapy Device is an Ultraviolet Light Emitting Medical Device. It is intended for use in localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and leukoderma on all skin types (I-VI). # VI. Comparison of Technological Characteristics With the Predicate Device The 308nm Ultraviolet Light Therapy Device has the same intended use as the predicate device and reference device. The technological characteristics such as wavelength, irradiance, power supply, are similar to the predicate device and reference device. Any minor differences between the subject device and the listed predicate device and reference device do no raise any issues of safety or efficacy. Performance data supports that the device is safe and as effective as the predicate device and reference device for its intended use. Therefore, the 308nm Ultraviolet Light Therapy Device(Models: XWYL-401A, XWYL-403A) may be found substantially equivalent to its predicate device. Page 2 of 7 {7} Guangxi Hope Medical Devices Technology Co., Ltd. 510(K) Summary of 308nm Ultraviolet Light Therapy Device | Comparison Elements | Subject Device | Predicate Device | Reference Device | Remark | | --- | --- | --- | --- | --- | | 510(k) Number | K262885 | K170489 | K191571 | / | | Trade name | 308nm Ultraviolet Light Therapy DeviceModels: XWYL-401A, XWYL-403A | Skylit Phototherapy SystemPhototherapy System | UV Radiation Treatment SystemModel: YK-6000A | / | | Device Picture | ![img-0.jpeg](img-0.jpeg) | ![img-1.jpeg](img-1.jpeg) | ![img-2.jpeg](img-2.jpeg) | / | | Regulation number | 21 CFR 878.4630 | 21 CFR 878.4630 | 21 CFR 878.4630 | Same | | Classification Name | Light, ultraviolet, dermatological | Light, ultraviolet, dermatological | Light, ultraviolet, dermatological | Same | | Product code | FTC | FTC | FTC | Same | | Device classification | Class II | Class II | Class II | Same | | Indication for use/ Intended use | The 308nm Ultraviolet Light Therapy Device is an Ultraviolet Light Emitting Medical Device. It is intended for use in localized phototherapeutic treatment of dermatologic conditions such as | The Clarify Medical Phototherapy System is an Ultraviolet Light Emitting Medical Device. It is intended for use in localized phototheraputic treatment of dermatologic conditions such as | The UV Radiation Treatment System models YK-6000A, YK-6000A-T, YK-6000B, and YK-6000B-T, are intended for use under the direction of a physician, for the treatment of vitiligo, psoriasis, and | Same | Page 3 of 7 {8} Guangxi Hope Medical Devices Technology Co., Ltd. 510(K) Summary of 308nm Ultraviolet Light Therapy Device--- | Comparison Elements | Subject Device | Predicate Device | Reference Device | Remark | | --- | --- | --- | --- | --- | | 510(k) Number | K262885 | K170489 | K191571 | / | | | psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and leukoderma on all skintypes (I-VI). | psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and lenkoderma on all skintypes (I-VI). | eczema. The devices are intended for treatment of these conditions on Fitzpatrick Skin Types (I-VI). | | | Prescription or OTC | Prescription Use | Prescription Use | Prescription Use | Same | | Use environment | Hospitals, clinics and homes | Home / Physician’s office | Hospitals, clinics and households | Same | | Mode of operation | Handheld | Handheld | Handheld | Same | | Dimension | XWYL-401A: 170*39*37mm XWYL-403A:200*39*37mm | Not Publicly Available | Not Publicly Available | Different This minor difference is insignificant and do not raise any safety or effectiveness problems. | | Weight | XWYL-401A: 130.7g XWYL-403A:154g | Not Publicly Available | Not Publicly Available | | | Power supply | DC5V, 1A Li-ion rechargeable Battery 18650-2600MAh 3.7V | Not Publicly Available | Not Publicly Available | Different The lithium battery of the subject device has passed IEC 62133-2 test, | Page 4 of 7 {9} Guangxi Hope Medical Devices Technology Co., Ltd. 510(K) Summary of 308nm Ultraviolet Light Therapy Device--- | Comparison Elements | Subject Device | Predicate Device | Reference Device | Remark | | --- | --- | --- | --- | --- | | 510(k) Number | K262885 | K170489 | K191571 | / | | | | | | so this difference should not raise any safety/effectiveness questions. | | Light source | LED UV lamps | LED UV lamps | LED UV lamps | Same | | UV Spectral | UVB | UVB | UVB | Same | | Location for use | Partial treatment excluding eyes | Partial treatment excluding eyes | Partial treatment excluding eyes | Same | | Wavelength | 308nm | 300nm-320nm | UVA: 320nm~400nm UVB: 300nm~320nm | Same | | Irradiance (mW/cm^{2}) | 13mW/cm^{2} | 3-15mW/cm^{2} | 10mW/cm^{2} | Same | | Treatment area | 4.5cm^{2} | 4.5cm^{2} | Max 15cm^{2} | Same | | Treatment time | 0-3 minutes | Not Publicly Available | 5~20 min | Same | | Compliance with voluntary standards | IEC 60601-1; IEC 60601-1-2; IEC 60601-1-11; IEC 60601-2-83; IEC 62471 | IEC 60601-1; IEC 60601-1-2; IEC 60601-1-4; IEC 60601-2-57; IEC 62471 | IEC 60601-1; IEC 60601-1-2; IEC 60601-2-57; IEC 62471 | Similar | Page 5 of 7 {10} Guangxi Hope Medical Devices Technology Co., Ltd. 510(K) Summary of 308nm Ultraviolet Light Therapy Device # VII. Performance Data The following performance data were provided in support of the substantial equivalence determination. # 1) Biocompatibility Testing The biocompatibility evaluation for the body-contacting components of the 308nm Ultraviolet Light Therapy Device was conducted in accordance with the “Use of International Standard ISO 10993-1, ‘Biological Evaluation of Medical Devices –Part 1: Evaluation and Testing Within a Risk Management Process, Document Issued on September 4, 2020”, as recommended by FDA. The following testing was performed to, and passed, including: > ISO 10993-5: 2009, Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity > ISO 10993-10: 2021, Biological evaluation of medical devices - Part 10: Tests for skin sensitization > ISO 10993-23: 2021, Biological evaluation of medical devices - Part 23: Tests for irritation # 2) Electrical Safety >IEC 60601-1:2014+A1:2020, Medical electrical equipment - Part 1: General requirements for basic safety and essential performance \(\succ\) IEC 60601-1-2:2014+A1:2020, Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests \(\succ\) IEC TS 60601-4-2::2024, Medical electrical equipment - Part 4-2: Guidance and interpretation -Electromagnetic immunity: performance of medical electrical equipment and medical electrical systems \(\succ\) IEC 60601-1-6::2024, Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability \(\succ\) IEC 60601-1-11:2015, Medical Electrical Equipment -Part 1-11: General Requirements for Basic Safety and Essential Performance -Collateral Standard: Requirements for Medical Electrical Equipment and Medical Electrical Systems Used in the Home Healthcare Environment \(\succ\) IEC 60601-2-83:2019, Medical electrical equipment - Part 2-83: Particular requirements for the basic safety and essential performance of home light therapy equipment \(\succ\) IEC 62133-2:2017, Secondary cells and batteries containing alkaline or other non-acid electrolytes -Safety requirements for portable sealed secondary cells, and for batteries made from them, for use in portable applications - Part 2: Lithium systems # 3) Eye Safety IEC 62471:2006, Photobiological safety of lamps and lamp systems # 4) Software Verification and Validation Software documentation consistent with Basic Documentation level was submitted in this 510(k). System validation testing presented in this 510(k) demonstrated that all software requirement specifications are met and all software hazards have been mitigated to acceptable risk levels. Page 6 of 7 {11} Guangxi Hope Medical Devices Technology Co., Ltd. 510(K) Summary of 308nm Ultraviolet Light Therapy Device ### VIII. Conclusions Based on the above analysis and non-clinical tests performed, it can be concluded that the subject device is as safe, as effective, and performs as well as the legally marketed predicate device K170489. Page 7 of 7
Innolitics
Guidance Recalls

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...